A cross-sectional study of health insurance database in Japan: Real-world surveillance for treatment of pediatric gout/ hyperuricemia with urate lowering agents
Not Applicable
- Conditions
- Gout and Hyperuricemia
- Registration Number
- JPRN-UMIN000036029
- Lead Sponsor
- Teijin Pharma Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have malignancy. (This criteria is not applied for denominator when calculating diagnosis and treatment rates for gout/hyperuricemia.)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method